Drug Discovery/Medicinal Chemistry at UCLA: Xtandi and OthersSpeaker: Michael E. Jung, Ph.D.,
Distinguished Professor, Department of Chemistry, University of California, Los Angeles
Mike was born and raised in New Orleans, Louisiana, which may explain his gastronomic proclivities. He received a B.A. from Rice University in 1969 working with Richard Turner on polyolefinic cyclization to diterpenes of the kaurene type. As an NSF Predoctoral Fellow, he worked under the direction of Gilbert Stork at Columbia University on the use of vinyl silanes as annulation reagents, receiving his Ph.D. in 1973. In 1974, after a one-year NATO postdoctoral stint with Albert Eschenmoser at the ETH in Zürich, he joined the faculty at UCLA where he is currently a full professor.
When: May 10, 2017, 12:00 pm - 1:00 pm
Where: Neuroscience Research Building Auditorium, UCLA
The UCLA Clinical and Translational Science Institute (CTSI) is a research partnership of UCLA, Cedars-Sinai Medical Center, Charles R. Drew University of Medicine and Science and the Los Angeles Biomedical Institute at Harbor UCLA Medical Center. Its mission is to bring biomedical innovations to bear on the greatest health needs of Los Angeles—the largest and one of the most ethnically, socially and economically diverse counties in the United States. Its vision is to catalyze research that translates discoveries into tangible improvements in health care, disease prevention and treatment in Los Angeles County.
Co-Sponsors: The UCLA CTSI and the Eli & Edythe Broad Center of Regenerative Medicine and Stem Cell Research